Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma
Francesca Huwyler, Roland Giger, Ruben Bill, Daniel Rauch, Simon Haefliger · 2024
Read Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma by Francesca Huwyler, Roland Giger, Ruben Bill, Daniel Rauch, Simon Haefliger (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11615028.txt.
Description
Francesca Huwyler and co-authors studied whether response to a first round of chemotherapy predicts survival in advanced head and neck cancer, in a 2024 study. This opening chemotherapy, given before radiation with drugs or surgery, remains an option for locally advanced cases. Their single-center study looked back at patients treated at a major cancer center.
Of 48 patients who got the opening therapy, 33 could be judged for response on scans. Most got one of two drug pairs or triplets. About 70 percent shrank their tumors by at least 30 percent, and nearly all had disease control. Two-year survival figures are reported for the group, and nonresponders with throat tumors fared notably worse.
Catalog record
| CREATOR | Francesca Huwyler, Roland Giger, Ruben Bill, Daniel Rauch, Simon Haefliger |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |